Content uploaded by Abhinandan Patil
Author content
All content in this area was uploaded by Abhinandan Patil on Apr 20, 2022
Content may be subject to copyright.
International Journal of Innovative Science Engineering and Technology (IJISET) GETAR-2019
18
Department of Pharmacology D. Y. Patil University, Kolhapur
The origin of novel coronavirus: COVID-19
Abhinandan Patil 1, 2, Shivaji Pawar 3
1 Chate Group of Education, Kolhapur (MS). India
2 Life Inspiration Social Foundation, Kolhapur (MS). India
3 Centre for Innovative and Applied Research, Anekant Education Society, Baramati, (MS).
India
* Correspondence author: Shivaji Pawar
Email: shpawar1946@gmail.com
Abstract
The new respiratory disease frequently observed are zoonoses exhibiting positive-stranded RNA viruses called
Coronaviruses (CoVs). These groups of the virus are having origin from non-human species such as bats, cows
and birds. The transmission of the virus to humans is reported to cause severe acute respiratory infection from
cough to pneumonia. The mortality rate is increased from its origin from severe acute respiratory syndrome
(SARS), Middle East respiratory syndrome (MERS) to newly developed COVID-19. The following review states
that the SARS, MERS to newly developed COVID-19 are generally types of coronavirus. The mode of infection
and symptoms exhibited by all the corona types are nearly the same but with the difference in its virulence.
1. Introduction
Emerging new diseases are frequently zoonoses developed from the positive-stranded RNA viruses called
Coronaviruses (CoVs) was found associated with common cold symptoms [1]. These viruses mostly infect the
upper respiratory system of the mammals including humans. The source of the virus and identification of its
reservoirs along with its mode of transmission between the hosts clarifies the difference. Infectious bronchitis
virus (IBV) was the first coronavirus to be isolated from domestic fowls in the late 1930s [2]. But, this virus has
not been reported to cause any human clinical disease. These avian coronaviruses have been found in nondomestic
avian species like peafowl, pheasant, teal, turkey, penguins, pigeon, duck, and Amazon parrot [3]. Further, the
coronavirus types causing minor infection in humans are 229E, NL63, OC43, and HKU1 [4]. Rarely these
coronaviruses may precipitate pneumonia or bronchitis in the human host. Two species HCoV-229E and
subsequently HCoV-OC43 were found to cause severe lower respiratory tract infection in immune-compromised
patients and elderly patients (Jean et al., 2013, p. 43). Similarly, in 2004 Holland another novel human coronavirus
(HCoV-NL63) was reported from infant (7 months) suffering from respiratory symptoms [5]. This virus also
infected other children and the immune-compromised, exhibiting mild upper respiratory symptoms along with
rhinorrhoea along with bronchiolitis and croup. A positive novel human coronavirus (HCoV-OC43) respiratory
specimens was reported in a pediatric hospital in Montreal (2010). HCoV-OC43 is a member of the
species Betacoronavirus 1 found to infect humans and cattle showing both upper and lower respiratory tract
infections along with cold-like symptoms [6]. In 2005, a novel coronavirus HCoV-HKU1, was reported in patients
of Hong Kong showing pneumonitis [7]. Thus, Coronavirus is a group of related viruses that cause diseases
in mammals and birds.
2. Pandemic eruption by a different novel coronavirus
Coronavirus investigators found that severe acute respiratory syndrome infected infants and old age persons. New
advances in the medical sciences of coronaviruses have developed a greater understanding of the trans-species
International Journal of Innovative Science Engineering and Technology (IJISET) GETAR-2019
19
Department of Pharmacology D. Y. Patil University, Kolhapur
infection, and pathogenesis of new diseases. The newly emerged zoonotic coronavirus: severe acute respiratory
syndrome (SARS-CoV) was declared as a pandemic outbreak (SARS) in 2002–2003 caused by order Nidovirales,
Coronavirus [8]. Similarly, other coronaviruses have spread from different host species from time to time causing
emerging diseases.
The first human cases of SARS were reported to be caused by coronaviruses, from the source of masked palm
civets and raccoon dogs which acted as an intermediate source of infection. Many survey studies reported a wide
variety of sources of coronaviruses from a bat species in Asian countries. Horseshoe-nosed bats found in different
locations of China and Hong Kong were found as a source of SARS-like CoVs in which these bats had found to
develop their natural antibodies to tackle these coronaviruses [9]. SARS was the first reported as a pandemic in
2003, where 8,097 cases were found with 774 deaths around 30 countries globally [10].
The incubation period of SARS reported is 2 to 14 days. Few cases showed longer incubation periods for more
than 14 days. Symptoms reported are the same as that of regular influenza virus, where the patients first fall ill
within 2 days and become eligible to transmit the infection from symptomatic SARS after the fifth day of onset
of disease with higher viral load in nasopharyngeal droplets [8].
Middle East respiratory syndrome coronavirus (MERS-CoV) was first reported in 2012. The MERS-CoV is a
novel coronavirus that was earlier designated as HCoV-EMC [11]. Similarly, MERS-CoV also found to causes
mild to fulminant respiratory tract infection. The clinical manifestation found in the case of MERS-CoV is similar
to SARS. Bats are considered as the major suspects in terms of zoonotic infection of both MERS-CoV and SARS.
MERS-CoV is a genetically the single-stranded RNA virus belonging to the family Coronaviridae same as that of
other coronavirus reported. Monkeys, raccoon dogs, Himalayan palm civets, dogs, cats, and rodents are found
susceptible to MERS-CoV [11]. It was stated that this virus transmitted in bats from camels. From camels, it was
transmitted to humans, but the reason is unclear.
3. COVID-19 as novel coronavirus
The SARS-CoV-2 also called a COVID-19 epidemic was reported in late December 2019 in Wuhan, China.
Earlier, A pneumonia of unknown cause was detected in China was first reported to the WHO Country Office in
China on 31 December 2019 [12]. The outbreak was declared a Public Health Emergency of International Concern
on 30 January 2020. People who become infected developed serious illnesses mostly difficulty in breathing. Older
people, and those with underlying medical problems like high blood pressure, heart problems or diabetes, are
reported likely to develop serious illness. Studies to date suggest that the virus that causes COVID -19 is mainly
transmitted through contact with respiratory droplets rather than through the air. It was found that molecular
divergence is less between SARS-CoV-2 and COVID-19. The scientist found about 4% variability in genomic
nucleotides of bat SARS and a bat SARS-CoV-2.
International Journal of Innovative Science Engineering and Technology (IJISET) GETAR-2019
20
Department of Pharmacology D. Y. Patil University, Kolhapur
Fig.1. Types of coronavirus
4. Pathogenesis found in all above-mentioned coronavirus shows
Several distinct features such as pneumonia with epithelial cell proliferation are reported in patients infected by a
coronavirus. Few reported macrophage infiltrations of the lungs along with the haemophagocytosis [13].
Symptoms
SARS
MERS
COVID-19
IBV
(in the avian
group, not in
human )
229E, NL63, OC43, and
HKU1
Fever
**
**
***
**
**
Dry cough
*
*
***
-
*
Runny nose
***
***
*
-
***
pneumonia
**
**
***
Extra-
pulmonary
damage
**
Shortness of
breath
**
**
***
**
**
Coronavirus
types
SARS
IBV
Animal
corona
229E, NL63,
OC43, and
HKU1
COVID-19
MERS
International Journal of Innovative Science Engineering and Technology (IJISET) GETAR-2019
21
Department of Pharmacology D. Y. Patil University, Kolhapur
Chills and
muscle
aches,
**
**
***
**
**
Headache
**
**
**
-
**
Diarrhea
*
**
***
-
**
sore throat
***
**
***
-
**
rash
***
***
*
-
***
Other
specific
Tachypnea (34
respirations/minute),
dyspnea, and hypoxemia
*- minor symptoms, **- mostly observed symptoms, ***- majorly observed symptoms, - data not available.
Many research is going on to check that use of probiotics or neutraceuticals can prevent the infection by
antioxidant mechanism along with existing drugs available in the market [14–21].
5. Mode of transmission
The interaction of the coronavirus antigenic spike protein is complementary with the host cell receptor exhibiting
tissue tropism and infectivity [22]. The transmission primary mode of COVID-19 is via respiratory droplets from
an infected person. This generally spreads from coughs, sneezes, or talks. The fomite borne transmission is by
settling of the droplets of an infected person on the nose, eyes or mouth of a healthy
individual. Coronaviruses remain for several days on surfaces of metal, glass, or plastic for several days. The
transmission also spread by touching the face with hands contaminated by fomite mode. Respiratory droplets
settle due to heaviness as compared to air, hence, a distance of more than six feet prevent the spread of infection
from the suspected person
The basic transmission of infection is mostly by the droplet mode while it is unclear if airborne transmission
occurs with COVID-19 infection. It is thus suggested the application of protective measures, including N95 masks.
In general, the Coronavirus spread can be prevented by [2,4]:
Covering the mouth during coughing and sneezing to avoid the droplets containing the virus to spread in the air
Isolating the infected person who’s already carrying the virus from healthy individuals
Avoiding any contact with the object which contains the virus and then touching your nose or mouth
6. Conclusion
Coronavirus has affected the globe from time to time since the 20th Century by its different forms. The COVID-
19 is one of the types of Coronavirus that developed pandemic infection such as SARS, MERS, etc. The word
corona should be confused with the only COVID-19, but it is one type of acute respiratory infection such as SARS,
MERS, etc. The symptoms observed in the case of all Corona subtypes are more or less similar. Thus Corona can
briefly be called to all subtypes such as SARS, MERS and the newly evolved COVID-19.
International Journal of Innovative Science Engineering and Technology (IJISET) GETAR-2019
22
Department of Pharmacology D. Y. Patil University, Kolhapur
References
[1] Huynh J, Li S, Yount B, Smith A, Sturges L, Olsen JC, et al. Evidence Supporting a
Zoonotic Origin of Human Coronavirus Strain NL63. J Virol 2012;86:12816–25.
https://doi.org/10.1128/JVI.00906-12.
[2] Amarasinghe A, Abdul-Cader MS, Nazir S, De Silva Senapathi U, van der Meer F,
Cork SC, et al. Infectious bronchitis corona virus establishes productive infection in
avian macrophages interfering with selected antimicrobial functions. PloS One
2017;12:e0181801. https://doi.org/10.1371/journal.pone.0181801.
[3] Smith J, Sadeyen J-R, Cavanagh D, Kaiser P, Burt DW. The early immune response to
infection of chickens with Infectious Bronchitis Virus (IBV) in susceptible and resistant
birds. BMC Vet Res 2015;11:256. https://doi.org/10.1186/s12917-015-0575-6.
[4] Vassilara F, Spyridaki A, Pothitos G, Deliveliotou A, Papadopoulos A. A Rare Case of
Human Coronavirus 229E Associated with Acute Respiratory Distress Syndrome in a
Healthy Adult. Case Rep Infect Dis 2018.
https://doi.org/https://doi.org/10.1155/2018/6796839.
[5] Abdul-Rasool S, Fielding BC. Understanding Human Coronavirus HCoV-NL63. Open
Virol J 2010;4:76–84. https://doi.org/10.2174/1874357901004010076.
[6] Lecis R, Mucedda M, Pidinchedda E, Pittau M, Alberti A. Molecular identification of
Betacoronavirus in bats from Sardinia (Italy): first detection and phylogeny. Virus
Genes 2019;55:60–7. https://doi.org/10.1007/s11262-018-1614-8.
[7] Vabret A, Dina J, Gouarin S, Petitjean J, Corbet S, Freymuth F. Detection of the New
Human Coronavirus HKU1: A Report of 6 Cases. Clin Infect Dis 2006;42:634–9.
https://doi.org/10.1086/500136.
[8] Vijayanand P, Wilkins E, Woodhead M. Severe acute respiratory syndrome (SARS): a
review. Clin Med 2004;4:152–60. https://doi.org/10.7861/clinmedicine.4-2-152.
[9] Wang L-F, Shi Z, Zhang S, Field H, Daszak P, Eaton BT. Review of Bats and SARS.
Emerg Infect Dis 2006;12:1834–40. https://doi.org/10.3201/eid1212.060401.
[10] LeDuc JW, Barry MA. SARS, the First Pandemic of the 21st Century1. Emerg Infect
Dis 2004;10:e26. https://doi.org/10.3201/eid1011.040797_02.
[11] Mubarak A, Alturaiki W, Hemida MG. Middle East Respiratory Syndrome Coronavirus
(MERS-CoV): Infection, Immunological Response, and Vaccine Development. J
Immunol Res 2019. https://doi.org/https://doi.org/10.1155/2019/6491738.
[12] Xiang Y-T, Li W, Zhang Q, Jin Y, Rao W-W, Zeng L-N, et al. Timely research papers
about COVID-19 in China. The Lancet 2020;395:684–5. https://doi.org/10.1016/S0140-
6736(20)30375-5.
[13] Weiss SR, Navas-Martin S. Coronavirus Pathogenesis and the Emerging Pathogen
Severe Acute Respiratory Syndrome Coronavirus. Microbiol Mol Biol Rev
2005;69:635–64. https://doi.org/10.1128/MMBR.69.4.635-664.2005.
[14] Abhinandan Patil, Shivaji Pawar, John Disouza. GRANULES OF UNISTRAIN
LACTOBACILLUS AS NUTRACEUTICAL ANTIOXIDANT AGENT 2017;9:1594–
9. https://doi.org/10.13040/IJPSR.0975-8232.9(4).1594-99.
[15] Abhinandan Patil, Pawar S. Health benefits of Probiotics by Antioxidant Activity: A
review. Pharma Times 2018;50:1–3.
[16] Patil A, Dubey A, Malla MA, Disouza J, Pawar S, Alqarawi AA, et al. Complete
Genome Sequence of Lactobacillus plantarum Strain JDARSH, Isolated from Sheep
Milk. Microbiol Resour Announc 2020;9. https://doi.org/10.1128/MRA.01199-19.
International Journal of Innovative Science Engineering and Technology (IJISET) GETAR-2019
23
Department of Pharmacology D. Y. Patil University, Kolhapur
[17] Patil A, Disouza J, Pawar S. Shelf life stability of encapsulated lactic acid bacteria
isolated from Sheep milk thrived in different milk as natural media. Small Rumin Res
2019;170:19–25. https://doi.org/10.1016/j.smallrumres.2018.09.014.
[18] Patil A, Disouza J, Pawar S. Evaluation of Lactobacillus plantarum growth in milk of
Indian buffalo breeds based on its physico-chemical content. Buffalo Bull 2019;38:345–
52.
[19] Patil A, Shivaji Pawar, John Disouza. Lactobacillus rhamnosus ARJD as a Functional
Food with Potential Antioxidant and Antibacterial Abilities 2019;3:1–8.
[20] Patil A, Disouza J, Shivaji Pawar. Probiotic potential of Lactobacillus plantarum with
the cell adhesion properties. J Glob Pharma Technol 2018;10:1–6.
[21] Patil AR, Shinde SS, Kakade PS, D’souza JI. LactobacillusModel Moiety a New Era
Dosage Form as Nutraceuticals and Therapeutic Mediator. Biotechnol. Bioforensics,
Springer, Singapore; 2015, p. 11–21. https://doi.org/10.1007/978-981-287-050-6_2.
[22] Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, et al. First
known person-to-person transmission of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in the USA. The Lancet 2020;395:1137–44.
https://doi.org/10.1016/S0140-6736(20)30607-3.